HeartSciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- HeartSciences Inc.
- Former names
- Heart Test Laboratories, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 6199 — Finance Services
- Jurisdiction of incorporation
- Texas
- Headquarters city
- Southlake
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- April
- Ticker symbol
- HSCS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001468492
- EIN
- 26-1344466
Board of directors
-
Andrew Simpson · Director · See RemarksSince 2023
-
Brian Szymczak · DirectorSince 2023
-
Bruce Bent · DirectorSince 2023
-
David R. Wells · DirectorSince 2022
-
Mark T. Hilz · Director · COO, Secretary and DirectorSince 2023
Director election results
Annual meeting of April 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Andrew Simpson Director, Officer (See Remarks) | Grant or award | +425,000 | — | — |
| Nov 28, 2025 | Andrew Simpson Director, Officer (See Remarks) | Grant or award | +70,000 | — | — |
| Jul 29, 2025 | Mark T. Hilz Director, Officer (COO, Secretary and Director) | Open-market sale | −4,416 | $3.54 | $15,633 |
| Aug 12, 2024 | Andrew Simpson Director, Officer (See Remarks) | Other | +17 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.